Powered by Lingsoft® Search Expander  | |
RSSCerebral Vasospasm | ||||||||||||||||||
 |
| |||||||||||||||||
| ||||||||||||||||||
 | | | ||||||||||||||||
| Table of contents 1. Advances in vasospasm research M. Murray, Nicholas W. C. Dorsch 2. Pre-vasospasm: early brain injury J. Cahill, John H. Zhang 3. Apoptotic markers in vasospasm after an experimental subarachnoid haemorrhage J. Cahill, I. Solaroglu, John H. Zhang 4. Cerebrospinal fluid soluble Fas and Fas ligand levels after aneurysmal subarachnoid haemorrhage Ali Metin Kafadar, M. Uzan, T. Tanriverdi, G. Z. Sanus, H. Uzun, M. Y. Kaynar, C. Kuday 5. Time course of oxyhemoglobin induces apoptosis in mice brain cells Wei Shi, L. Y. Huang, R. Z. Wang, J. J. Sun, F. R. Wang, C. X. Liu, L. Zhou, J. H. Zhang 6. Inhibition of c-Jun N-terminal kinase pathway attenuates cerebral vasospasm after experimental subarachnoid hemorrhage through the suppression of apoptosis H. Yatsushige, M. Yamaguchi-Okada, C. Zhou, J. W. Calvert, J. Cahill, A. R. T. Colohan, John H. Zhang 7. Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm R. E. Ayer, J. H. Zhang 8. Bilirubin oxidation products (BOXes): synthesis, stability and chemical characteristics W. L. Wurster, G. J. Pyne-Geithman, I. R. Peat, Joseph F. Clark 9. Vascular contractility changes due to vasospasm induced by periarterial whole blood and thrombocyte rich plasma Goksin Sengul, H. H. Kadioglu 10. Vasospasm biochemistry Shigeru Nishizawa 11. The roles of cross-talk mechanisms in the signal transduction systems in the pathophysiology of the cerebral vasospasm after subarachnoid haemorrhage — what we know and what we do not know Shigeru Nishizawa, M. Koide, M. Yamaguchi-Okada 12. Subarachnoid hemorrhage induces upregulation of vascular receptors and reduction in rCBF via an ERK1/2 mechanism Saema Ansar, J. Hansen-Schwartz, L. Edvinsson 13. Effect of deferoxamine-activated hypoxia inducible factor-1 on the brainstem following subarachnoid haemorrhage S. Ono, Tomohito Hishikawa, T. Ogawa, M. Nishiguchi, K. Onoda, K. Tokunaga, K. Sugiu, I. Date 14. Urgosedin downregulates mRNA expression of TNF- S. -C. Chen, S. -C. Wu, Y. -C. Lo, S. -Y. Huang, W. Winardi, D. Winardi, I. -J. Chen, S. -L. Howng, Aij-Lie Kwan 15. Nucleotide-induced cerebral vasospasm in an Anthony Jabre, A. Patel, L. Macyszyn, D. Taylor, M. Keady, Y. Bao, J. -F. Chen 16. Effects of ADPbetaS on purine receptor expression in mouse cerebral vasculature Anthony Jabre, L. Macyszyn, M. Keady, Y. Bao, A. Patel, J. -F. Chen 17. Electrophysiology of cerebral vasospasm A. Kawashima, R. Loch Macdonald 18. Cellular basis of vasospasm: role of small diameter arteries and voltage-dependent Ca M. Ishiguro, George C. Wellman 19. Acute and chronic effects of oxyhemoglobin on voltage-dependent ion channels in cerebral arteries M. Ishiguro, K. Murakami, T. Link, K. Zvarova, B. I. Tranmer, A. D. Morielli, George C. Wellman 20. The effect of an intracisternal nimodipine slow-release system on cerebral vasospasm after experimental subarachnoid haemorrhage in the rat D. Hänggi, B. Turowski, J. Perrin, M. Rapp, J. Liersch, M. Sabel, H. -J. Steiger 21. Cerebral vasospasm following subarachnoid haemorrhage is completely prevented by L-type calcium channel antagonist in human H. Kasuya, H. Onda, B. Krischek, T. Hori 22. Vasospasm pharmacology Hartmut Vatter, V. Seifert 23. Endothelin-converting enzyme inhibitor versus cerebrovasospasm W. Winardi, A. L. Kwan, C. L. Lin, A. Y. Jeng, K. I. Cheng 24. A pharmacokinetic study of clazosentan in patients with aneurysmal subarachnoid haemorrhage P. L. M. Giersbergen, P. Vajkoczy, B. Meyer, S. Weidauer, A. Raabe, C. Thome, F. Ringel, V. Breu, P. Schmiedek, Jasper Dingemanse 25. Pharmacokinetic and pharmacodynamic aspects of the interaction between clazosentan and nimodipine in healthy subjects P. L. M. Giersbergen, Jasper Dingemanse 26. Attenuation of intercellular adhesion molecule-1 and cerebral vasospasm in rabbits subjected to experimental subarachnoid haemorrhage by CGS 26303 C. L. Lin, K. I. Cheng, D. Winardi, K. S. Chu, S. C. Wu, S. I. Lue, D. I. Chen, C. S. Liu, A. Y. Jeng, A. L. Kwan 27. The effect of 17 Y. F. Su, C. L. Lin, A. S. Lieu, K. S. Lee, C. J. Wang, C. Z. Chang, T. F. Chan, K. I. Cheng, S. L. Howng, A. L. Kwan 28. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH Ryszard M. Pluta 29. An adenosine A C. L. Lin, C. Z. Chang, Y. F. Su, A. S. Lieu, K. S. Lee, J. K. Loh, T. F. Chan, C. J. Wang, S. L. Howng, A. L. Kwan 30. Gene transfer after subarachnoid hemorrhage: a tool and potential therapy Donald D. Heistad, Y. Watanabe, Y. Chu 31. Direct protein transduction method to cerebral arteries by using 11R: new strategy for the treatment of cerebral vasospasm after subarachnoid haemorrhage Tomoyuki Ogawa, S. Ono, T. Ichikawa, H. Michiue, S. Arimitsu, K. Onoda, K. Tokunaga, K. Sugiu, K. Tomizawa, H. Matsui, I. Date 32. Endothelial nitric oxide synthase-11R protein therapy for prevention of cerebral vasospasm in rats: a preliminary report Tomoyuki Ogawa, S. Ono, T. Ichikawa, S. Arimitsu, K. Onoda, K. Tokunaga, K. Sugiu, K. Tomizawa, H. Matsui, I. Date 33. Microarray analysis of hemolysate-induced differential gene expression in cultured human vascular smooth muscle cells (HVSMC) T. Sasaki, Hidetoshi Kasuya, Y. Aihara, T. Hori 34. Role of vascular remodeling in cerebral vasospasm Hiroki Ohkuma, A. Munakata, S. Suzuki 35. Possible role of tenascin-C in cerebral vasospasm after aneurysmal subarachnoid haemorrhage Hidenori Suzuki, K. Kanamaru, Y. Suzuki, Y. Aimi, N. Matsubara, T. Araki, M. Takayasu, T. Takeuchi, K. Okada, N. Kinoshita, K. Imanaka-Yoshida, T. Yoshida, W. Taki 36. Ecdysterone-sensitive smooth muscle cell proliferation stimulated by conditioned medium of endothelial cells cultured with bloody cerebrospinal fluid Z. Chen, G. Zhu, J. H. Zhang, Z. Liu, W. Tang, Hua Feng 37. The effect of oxyhemoglobin on the proliferation and migration of cultured vascular advential fibroblasts W. -H. Tang, G. Zhu, J. H. Zhang, Z. Chen, Z. Liu, Hua Feng 38. The effect of oxyhemoglobin on the proliferation and migration of cultured vascular smooth muscle cells W. -H. Tang, G. Zhu, J. H. Zhang, Z. Chen, Z. Liu, Hua Feng 39. Comparison of three measurement methods for basilar artery with neurological changes in rabbits subjected to experimental subarachnoid hemorrhage J. R. Kuo, C. P. Yen, S. C. Wu, Y. F. Su, S. L. Howng, A. L. Kwan, A. Y. Jeng, W. Winardi, N. F. Kassell, Chih-Zen Chang 40. Vasospasm diagnosis strategies Peter Vajkoczy, E. Münch 41. Continuous evaluation of regional oxygen saturation in cerebral vasospasm after subarachnoid haemorrhage using INVOS Shigeki Ono, S. Arimitsu, T. Ogawa, H. Manabe, K. Onoda, K. Tokunaga, K. Sugiu, I. Date 42. Automated voxel-based analysis of brain perfusion SPECT for vasospasm after subarachnoid haemorrhage Satoshi Iwabuchi, T. Yokouchi, H. Terada, M. Hayashi, H. Kimura, A. Tomiyama, Y. Hirata, N. Saito, J. Harashina, H. Nakayama, K. Sato, K. Hamazaki, K. Aoki, H. Samejima, M. Ueda 43. Angiographic scale for evaluation of cerebral vasospasm Edgar Nathal, F. Lóopez-González, C. Rios 44. CT evaluation of late cerebral infarction after operation for ruptured cerebral aneurysm Hiroshi Wanifuchi, A. Sasahara, S. Sato 45. Elevated intracranial pressure or subarachnoid blood responsible for reduction in cerebral blood flow after SAH Saema Ansar, L. Edvinsson 46. Magnetic resonance imaging in the canine double-haemorrhage subarachnoid haemorrhage model T. Sugawara, A. Wang, V. Jadhav, T. Tsubokawa, A. Obenaus, John H. Zhang 47. Perfusion/diffusion-weighted imaging protocol for the diagnosis of cerebral vasospasm and management of treatment after subarachnoid haemorrhage Jürgen Beck, A. Raabe, H. Lanfermann, J. Berkefeld, R. Mesnil de Rochemont, F. Zanella, V. Seifert, S. Weidauer 48. Diffusion and perfusion MRI findings with clinical correlation in patients with subarachnoid haemorrhage related vasospasm Serra Sencer, T. Kiris, A. Sencer, U. Yaka, M. Sahinbas, K. Aydin, B. Tiryaki, A. Karasu, O. Agus, M. Ozkan, M. Imer, F. Unal 49. Correlation of end-tidal CO B. Schatlo, S. Gläsker, A. Zauner, G. B. Thompson, E. H. Oldfield, Ryszard Pluta 50. A diagnostic flowchart, including TCD, Xe-CT and angiography, to improve the diagnosis of vasospasm critically affecting cerebral blood flow in patients with subarachnoid haemorrhage, sedated and ventilated Arturo Chieregato, R. Battaglia, G. Sabia, C. Compagnone, F. Cocciolo, F. Tagliaferri, R. Pascarella, U. Pasquini, M. Frattarelli, L. Targa 51. Basilar artery vasospasm: diagnosis and grading by transcranial Doppler Gill E. Sviri, M. Zaaroor, G. W. Britz, C. M. Douville, A. Lam, D. W. Newell 52. Predictive value of transcranial Doppler to detect clinical vasospasm in patients with aneurysmal subarachnoid haemorrhage Meltem Can, O. Kahyaoglu, I. Çolak, Y. Aydin 53. Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a meta-analysis of published data G. K. Wong, W. S. Poon, M. T. V. Chan 54. Hypomagnesemia after ruptured middle cerebral artery aneurysms: predictive factor and pathophysiological implication G. K. Wong, W. S. Poon, M. T. V. Chan 55. The role of magnesium sulfate in the treatment of vasospasm in patients with spontaneous subarachnoid haemorrhage Kostas N. Fountas, T. G. Machinis, J. S. Robinson, C. Sevin, N. I. Fezoulidis, M. Castresana, E. Z. Kapsalaki 56. Fasudil (a rho-kinase inhibitor) may specifically increase rCBF in spastic area Masato Shibuya, A. Ikeda, K. Ohsuka, Y. Yamamoto, S. Satoh 57. Multimodality therapy for cerebral vasospasm after SAH: importance of intensive care and intraarterial injection of fasudil hydrochloride Shigeki Ono, S. Arimitsu, T. Ogawa, K. Onoda, K. Tokunaga, K. Sugiu, I. Date 58. The effect of KMUVS-1 on experimental subarachnoid haemorrhage-induced cerebrovasospasm K. -C. Sung, C. -P. Yen, J. -H. Hsu, S. -C. Wu, Y. -C. Wu, S. -I. Lue, W. Winardi, K. -I. Cheng, Aij-Lie Kwan 59. Role of statins in cerebral vasospasm T. Sugawara, R. Ayer, John H. Zhang 60. Treatment of cerebral vasospasm with cilostazol in subarachnoid haemorrhage model Burçak Bilginer, B. Öal, K. Yigitkanli, F. Söylemezoglu, M. Bavbek, I. M. Ziyal, T. Özgen 61. Ecdysterone attenuates vasospasm following experimental subarachnoid haemorrhage in rabbits Z. Liu, G. Zhu, J. H. Zhang, Z. Chen, W. -H. Tang, X. -R. Wang, Feng Hua 62. Clot-clearance rate in the sylvian cistern is associated with severity of cerebral vasospasm after subarachnoid haemorrhage Tomikatsu Toyoda, T. Ohta, T. Kin, T. Tanishima 63. Simultaneous head rotation and lumboventricular lavage in patients after severe subarachnoid haemorrhage: an initial analysis of the influence on clot clearance rate and cerebral vasospasm Daniel Hänggi, J. Liersch, G. Wöbker, H. -J. Steiger 64. Intrathecal urokinase infusion through a microcatheter into the cisterna magna to prevent cerebral vasospasm: experimental study in dogs Yutaka Kai, M. Morioka, S. Yano, T. Mizuno, J. -I. Kuratsu, J. -I. Hamada, T. Todaka 65. Microcatheter intrathecal urokinase infusion into cisterna magna for prevention of cerebral vasospasm Yasuhiko Hayashi, Y. Kai, M. Mohri, N. Uchiyama, J. -I. Hamada 66. Prevention of symptomatic vasospasm — effect of continuous cisternal irrigation with urokinase and ascorbic acid Namio Kodama, T. Sasaki, M. Matsumoto, K. Suzuki, J. Sakuma, Y. Endo, M. Oinuma, T. Ishikawa, T. Sato 67. Cisternal washing therapy for the prevention of cerebral vasospasm following SAH: analysis of 308 consecutive cases with Fisher group 3 SAH Tadayoshi Nakagomi, T. Ishii, K. Furuya, H. Nagashima, M. Hirata, A. Tamura 68. Questionable value of decompressive craniectomy after severe aneurysmal subarachnoid haemorrhage Matthias Jaeger, M. U. Schuhmann, J. Meixensberger 69. Low incidence of cerebral vasospasm after aneurysmal subarachnoid haemorrhage: a comparison between surgical repairs and endovascular coil occlusions Yoshikazu Yoshino, Y. Takasato, H. Masaoka, T. Hayakawa, N. Otani, H. Yatsushige, T. Sugawara, A. Kitahashi, Y. Obikane, C. Aoyagi 70. Microsurgical treatment of unruptured intracranial aneurysms Naci Balak, A. Çerçi, A. Serefhan, K. Coskun, R. Sari, N. Isik, I. Elmaci 71. Coil embolization decrease the incidence of symptomatic vasospasm, except in patients with poor grade subarachnoid hemorrhage Noritaka Aihara, M. Mase, K. Yamada 72. Endovascular therapy of cerebral vasospasm: two year experience with angioplasty and/or intraarterial administration of nicardipine and verapamil A. L. Delgado, B. Jahromi, N. Müller, H. Farhat, J. Salame, Alois Zauner 73. Utility of intra-arterial nimodipine for cerebral vasospasm Edgar Nathal, C. García-Perales, A. Lee, R. Ondarza, M. Zenteno 74. Intra-arterial nicardipine successfully relieved post-subarachnoid hemorrhage cerebral vasospasm during aneurysm embolization: a case report K.- C. Lin, C.-C. Chung, A.- L. Kwan, Y.- L. Kuo, S.- L. Howng, K.- A. Chang, S.- C. Wu, An-Kuo Chou 75. Evaluating the factors affecting cerebral vasospasm in patients after aneurysmal subarachonoid haemorrhage Mustafa Aziz Hatiboglu, K. Bikmaz, A. C. Iplikcioglu, N. Turgut 76. Is cerebral salt wasting after subarachnoid haemorrhage caused by bleeding? J. Kojima, Y. Katayama, T. Igarashi, M. Yoneko, K. Itoh, T. Kawamata, T. Mori, N. Moro 77. Relationship between the development of vasospasm after aneurysmal subarachnoid haemorrhage and the levels of dendroaspis natriuretic peptide in body fluids Alpay Serefhan, N. Balak, A. Çerçi, K. Coskun, R. Sari, G. Silav, N. Isik, M. Çelik, I. Elmaci 78. An abrupt fall in blood pressure in aneurysmal subarachnoid hemorrhage Sadaharu Tabuchi, N. Hirano, M. Tanabe, K. Akatsuka, T. Watanabe 79. C-reactive protein might predict outcome in aneurysmal subarachnoid haemorrhage Kostas N. Fountas, M. Kassam, T. G. Machinis, V. G. Dimopoulos, J. S. Robinson, M. Ajjan, A. A. Grigorian, E. Z. Kapsalaki 80. Factors affecting the incidence and severity of vasospasm after subarachnoid haemorrhage Mustafa Kemal Hamamcioglu, C. Kilincer, E. Altunrende, T. Hicdonmez, O. Simsek, S. Akyel, S. Cobanoglu 81. Basilar artery vasospasm: impact on outcome Gill E. Sviri, M. Zaaroor, G. W. Britz, C. M. Douville, A. Lam, D. W. Newell 82. Change of management results in good-grade aneurysm patients Sung-Don Kang 83. Quantification of transient ischemic and metabolic events in patients after subarachnoid haemorrhage Oliver W. Sakowitz, K. L. Krajewski, D. Haux, B. Orakcioglu, A. W. Unterberg, K. L. Kiening 84. Pediatric subarachnoid haemorrhage David L. Westra, A. R. T. Colohan 85. Childhood intracranial aneurysms Altay Sencer, T. Kiris, A. Aydoseli, B. Göker, B. Tatli, A. Karasu, K. Hepgül, N. Izgi, A. Canbolat 86. Pediatric cerebral aneurysms: a report of 9 cases Mehmet Tatli, A. Guzel, C. Kilincer, H. M. Goksel 87. Intracranial aneurysms during childhood and puberty A. Mosiewicz, P. Markiewicz, M. Szajner, Tomasz Trojanowski 88. Vasospasm in traumatic brain injury Sean S. Armin, A. R. T. Colohan, J. H. Zhang 89. Traumatic vasospasm S. Stein, Peter D. Roux 90. Cerebral vasospasm in diffuse axonal injury patients Mehdi Farhoudi, A. Zeinali, M. Aghajanloo, M. Asghari 91. The effects of nimopidine on platelet aggregation in severe head injury Mehmet Tatli, A. Guzel, C. Kilinçer, S. Batun 92. “Street drugs” and subarachnoid haemorrhage S. Ghostine, Austin Colohan DRM-restrictions Printing: not available Clipboard copying: not available | ||||||||||||||||||
| Emme toimita kirjojen mukana mahdollisesti tulevaa lisämateriaalia (esim. CD- tai DVD-levyjä). | ||||||||||||||||||
|
|
Lisää aiheesta
